top of page

EXC: Fauci, DOD, & CDC Funded Deadly Pathogen Research At Sudanese Biolab Seized By Militants.

Sudan’s National Public Health Laboratory – whose recent seizure by militants has prompted warnings of causing a “huge biological risk” – received financial and personnel support from U.S. government bodies including the Department of Defense, Centers for Disease Control and Prevention, and Dr. Anthony Fauci’s National Institutes of Health agency, War Room can reveal.

The stunning revelation follows Nima Saeed Abid, the World Health Organization (WHO) representative in Sudan, admitting the situation was “extremely dangerous” because “we have polio isolates in the lab, we have measles isolates in the lab, we have cholera isolates in the lab.” U.S. federal funding has directly supported research conducted by researchers from the high-risk laboratory into cholera.

“There is a huge biological risk associated with the occupation of the central public health lab in Khartoum by one of the fighting parties,” he added.

The lab, which is based in the country’s capital Khartoum, is a recipient of support from a variety U.S. government agencies including the Department of Defense (DOD), Centers for Disease Control and Prevention(CDC), and United States Agency for International Development (USAID). During Dr. Fauci’s tenure as a National Institutes of Health (NIH) agency leader, he also allocated funds to support research involving scientists from the controversial laboratory.

It turns out the Sudan biolab seized by militants has direct ties to the Bill & Melinda Gates Foundation and the Defence Threat Reduction Agency.

The biolab was working on a Phase 2 trial for Marburg “vaccines.”


Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits


LONDON, April 19, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotech company focused on the detection of immune responses to and diagnosis of viral diseases, announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.

The Marburg Virus Real Time PCR Kit is an in-vitro diagnostic test, based on real-time PCR technology, for the detection of ribonucleic acid (better known as RNA) from the Marburg Virus. The Company intends to launch the kit into areas accepting a CE mark.

Virax's Chairman of the Board and Chief Executive Officer, James Foster commented, "We are committed to developing and distributing innovative diagnostic tools to combat infectious diseases. Our Marburg Virus PCR testing kit is a significant step forward in our mission to improve global health."

The Marburg Virus Disease is a highly virulent disease which causes hemorrhagic fever and requires assessment under the International Health Regulations by the World Health Organization. Given the severity of the disease, the use of accurate and reliable test kits is critical to ensure the best possible outcomes for individuals affected by the disease, as well as for safeguarding public health more broadly.



bottom of page